INTERMITTENT HEPARIN TREATMENT DOES NOT INDUCE HYPER-COAGULABILITY IN HEMODIALYZED PATIENTS

被引:11
作者
PUSINERI, F
BINI, A
MUSSONI, L
REMUZZI, G
DONATI, MB
机构
[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[2] OSPED RIUNITI BERGAMO,DIV NEPHROL,I-24100 BERGAMO,ITALY
关键词
D O I
10.1136/jcp.33.7.631
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:631 / 634
页数:4
相关论文
共 17 条
[1]   METABOLISM OF ANTITHROMBIN-3 (HEPARIN COFACTOR) IN MAN - EFFECTS OF VENOUS THROMBOSIS AND OF HEPARIN ADMINISTRATION [J].
COLLEN, D ;
SCHETZ, J ;
DECOCK, F ;
HOLMER, E ;
VERSTRAETE, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (01) :27-35
[2]  
COOK MK, 1978, LANCET, V1, P208
[3]  
de Gaetano G, 1976, Thromb Res, V8, P361, DOI 10.1016/0049-3848(76)90029-3
[4]  
DENSON KWE, 1977, LANCET, V2, P1028
[5]   RATIO OF FACTOR-VIII-RELATED ANTIGEN AND FACTOR-VIII BIOLOGICAL-ACTIVITY AS AN INDEX OF HYPERCOAGULABILITY AND INTRAVASCULAR CLOTTING [J].
DENSON, KWE .
THROMBOSIS RESEARCH, 1977, 10 (01) :107-119
[6]  
JORGENSEN KA, 1977, LANCET, V2, P1231
[7]   ARTERIOVENOUS-SHUNT THROMBOSIS - PREVENTION BY SULFINPYRAZONE [J].
KAEGI, A ;
PINEO, GF ;
SHIMIZU, A ;
TRIVEDI, H ;
HIRSH, J ;
GENT, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (06) :304-306
[9]  
MARCINIAK E, 1977, LANCET, V2, P581
[10]  
OBRIEN JR, 1977, LANCET, V2, P1232